Low levels of HIV-1 drug resistance mutations in patients who achieved viral re-suppression without regimen switch: a retrospective study

[1]  Dumessa Edessa,et al.  Second-line HIV treatment failure in sub-Saharan Africa: A systematic review and meta-analysis , 2019, PloS one.

[2]  Chunfu Yang,et al.  Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options , 2017, Open forum infectious diseases.

[3]  C. Brites,et al.  Virological suppression in children and adolescents is not influenced by genotyping, but depends on optimal adherence to antiretroviral therapy , 2017, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[4]  Manuel Battegay,et al.  Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: an emerging public health concern , 2016, AIDS.

[5]  K. Klipstein‐Grobusch,et al.  Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa: a systematic review , 2016, BMJ Global Health.

[6]  C. Delaugerre,et al.  High efficacy of first-line ART in a West African cohort, assessed by dried blood spot virological and pharmacological measurements. , 2016, The Journal of antimicrobial chemotherapy.

[7]  S. Esser,et al.  A simple self‐reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy , 2016, HIV medicine.

[8]  C. Hoffmann,et al.  CD4 count‐based failure criteria combined with viral load monitoring may trigger worse switch decisions than viral load monitoring alone , 2016, Tropical medicine & international health : TM & IH.

[9]  E. Delaporte,et al.  Patterns of adherence to antiretroviral therapy and HIV drug resistance over time in the Stratall ANRS 12110/ESTHER trial in Cameroon , 2014, HIV medicine.

[10]  E. Owoaje,et al.  Prevalence and determinants of adherence to HAART amongst PLHIV in a tertiary health facility in south-south Nigeria , 2013, BMC Infectious Diseases.

[11]  A. Phillips,et al.  Viral Suppression Following Switch to Second-line Antiretroviral Therapy: Associations With Nucleoside Reverse Transcriptase Inhibitor Resistance and Subtherapeutic Drug Concentrations Prior to Switch , 2013, The Journal of infectious diseases.

[12]  S. Biadgilign,et al.  Determinants of Adherence to Antiretroviral Therapy among HIV-Infected Patients in Africa , 2012, AIDS research and treatment.

[13]  Erin K. Rottinghaus,et al.  Optimization of a Low Cost and Broadly Sensitive Genotyping Assay for HIV-1 Drug Resistance Surveillance and Monitoring in Resource-Limited Settings , 2011, PloS one.

[14]  H. Hospers,et al.  Measuring adherence to antiretroviral therapy in northern Tanzania: feasibility and acceptability of the Medication Event Monitoring System , 2011, BMC public health.

[15]  Peter M. A. Sloot,et al.  Comparison of HIV-1 Genotypic Resistance Test Interpretation Systems in Predicting Virological Outcomes Over Time , 2010, PloS one.

[16]  Robert J. Gifford,et al.  The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance , 2009, Bioinform..

[17]  I. Buchan,et al.  Adherence to HAART : A Systematic Review of Developed and Developing Nation Patient-Reported Barriers and Facilitators , 2006 .

[18]  Tommy F. Liu,et al.  Web resources for HIV type 1 genotypic-resistance test interpretation. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  G. Lucas.  Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: a tangled web is woven. , 2005, The Journal of antimicrobial chemotherapy.

[20]  Joel E Gallant,et al.  Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  H. Mcdonald,et al.  Interventions to enhance patient adherence to medication prescriptions: scientific review. , 2002, JAMA.

[22]  B. Turner.  Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients. , 2002, The Journal of infectious diseases.

[23]  Harry Reyes Nieva,et al.  Scale-up of networked HIV treatment in Nigeria: Creation of an integrated electronic medical records system , 2015, Int. J. Medical Informatics.